APCO WORLDWIDE LLC for HIKMA PHARMACEUTICALS USA INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade policies impacting domestic generic pharmaceutical manufacturing
Foreign entity interest: Hikma Pharmaceuticals PLC, identified in the LD-1, has an indirect interest in U.S. policy relating to health and pharmaceutical products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MIKASA MODI | — |
| ALLISON PARKER-LAGOO | Assistant to the Chief of Staff, Sen. Hagan |
| DAN SCANDLING | Chief of Staff & Press Secretary, Rep. Bateman |
Health Issues HCR
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Foreign entity interest: Hikma Pharmaceuticals PLC, identified in the LD-1, has an indirect interest in U.S. policy relating to health and pharmaceutical products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MIKASA MODI | — |
| ALLISON PARKER-LAGOO | Assistant to the Chief of Staff, Sen. Hagan |
| DAN SCANDLING | Chief of Staff & Press Secretary, Rep. Bateman |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.